Home > Boards > US Listed > Medical - Equipment > CUTERA, INC. (CUTR)

Introducing Pearl Fractional

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Soapy Bubbles Member Profile
 
Followed By 505
Posts 41,211
Boards Moderated 21
Alias Born 09/16/07
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:12:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/7/2020 5:09:46 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/3/2020 4:32:59 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/2/2020 4:46:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/18/2020 5:23:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/18/2020 5:22:01 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2020 5:07:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:39:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2020 5:54:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/3/2020 6:22:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2020 5:37:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2020 5:33:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2020 5:27:06 PM
Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results Business Wire - 2/26/2020 4:10:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 1:36:15 PM
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2019 Results on February 26, 2020 Business Wire - 2/13/2020 4:41:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 6:05:44 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 11:15:19 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/4/2020 11:58:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2020 6:03:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2020 5:09:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/13/2020 1:36:12 PM
Cutera Announces Preliminary Financial Results for Fourth Quarter and Full-Year 2019 Business Wire - 1/12/2020 7:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/10/2020 4:59:46 PM
Cutera to Present at the Piper Jaffray 31st Annual Healthcare Conference Business Wire - 12/2/2019 8:00:00 PM
Soapy Bubbles   Tuesday, 10/21/08 02:21:19 PM
Re: None
Post # of 19 
Introducing Pearl Fractional
The fractional ablative laser perfected for photoaging.
What is the Pearl Fractional laser?
The Pearl Fractional laser aggressively treats the signs of photoaging in addition to a broad range of dermal imperfections. Long term improvement may be achieved with a single treatment and patients typically experience only one week of downtime.

Engineered to improve upon current fractional ablative products, Cutera's proprietary YSGG 2790 nm wavelength is unique in the category as it optimizes the ratio of ablation to coagulation. Pearl Fractional removes tissue through a series of microcolumns, while simultaneously stimulating new collagen growth through a controlled zone of thermal coagulation.

Clinical Rationale
Traditionally, fine lines have been improved or eliminated through non-ablative or minimally invasive resurfacing procedures. However, there is a marked clinical need for a short downtime approach to treat diffuse facial photoaging, and/or cosmetic units, such as the upper lip and periorbital areas. Pearl Fractional's 2790 nm wavelength is aggressive enough to produce excellent results, yet predictable enough to deliver a high safety profile.

Mechanism of Action
Pearl Fractional's distinctive wavelength provides the perfect balance of ablation and thermal coagulation.
• 300 micron diameter spots maximize tissue ablation deep in the dermis
• Just the right amount of thermal coagulation controls bleeding
• A balanced approach optimizes patient results, treatment experience and downtime

YSGG Microcolumns
• Deep dermal ablation (> 1 mm) for maximum results in one treatment (1)
• Thermal coagulation reduces operative bleeding (2)
• Controlled thermal damage and minimal necrotic tissue improves healing time (3)
• Fewer complications due to minimal thermal overlap

http://www.cutera.com/product.asp?view=295



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist